Form C-AR - Annual Report:
SEC Accession No. 0001665160-24-000561
Filing Date
2024-04-26
Accepted
2024-04-26 13:51:30
Documents
2
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 primary_doc.html C-AR  
1 primary_doc.xml C-AR 3975
2 form_car.pdf EX-99 32014452
  Complete submission text file 0001665160-24-000561.txt   43093701
Mailing Address 1600 FAIRVIEW AVE E STE 300 SUITE 300 SEATTLE WA 98102
Business Address 1600 FAIRVIEW AVENUE EAST SUITE 300 SEATTLE WA 98102 2144788208
Deverra Therapeutics, Inc. (Filer) CIK: 0001822782 (see all company filings)

EIN.: 843312665 | State of Incorp.: DE
Type: C-AR | Act: 33 | File No.: 020-33895 | Film No.: 24881646